NewLeaf Symbiotics raises $20 million in a first close of its Series D financing


NewLeaf Symbiotics, Inc. has raised $20 million in a first close of its Series D financing with Koch Agronomic Holdings, Leaps by Bayer, Otter Capital, S2G Ventures and RockPort Capital as participants in the investment round.

NewLeaf focuses on M-trophs, a class of microbes that naturally colonize roots and leaves of plants, allowing for increased crop yield, protection against pests and diseases, enhancing grain and fruit quality, and improving plant nutrition. M-troph products are commercialized under the brand name of Terrasym.

As part of the financing plan, the company will continue to enhance its R&D and product platforms while commercializing into broad acre row crops – currently corn, soybeans and peanuts. NewLeaf will also continue to work with Joyn Bio as it develops its microbial engineering platform around NewLeaf’s beneficial plant colonizing microbes.

As NewLeaf focuses on advancing commercialization, a streamlined management team has been formed. Co-founder Steve Kahn will lead the company as CEO, while Tom Laurita, co-founder and former CEO, will remain involved as a senior consultant.

More information:



NAI56 Cover199x282


News From Suppliers